Evidence map›Paper›PMID 40026592›Full record

ArticleMethodsX2025

IM- LTS: An Integrated Model for Lung Tumor Segmentation using Neural Networks and IoMT.

Jayapradha J, Su-Cheng Haw, Naveen Palanichamy, Kok-Why Ng, Senthil Kumar Thillaigovindhan

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jayapradha JDepartment of Computing Technologies, School of Computing, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India.
Su-Cheng HawFaculty of Computing and Informatics, Multimedia University, Jalan Multimedia, 63100 Cyberjaya, Malaysia.
Naveen PalanichamyFaculty of Computing and Informatics, Multimedia University, Jalan Multimedia, 63100 Cyberjaya, Malaysia.
Kok-Why NgFaculty of Computing and Informatics, Multimedia University, Jalan Multimedia, 63100 Cyberjaya, Malaysia.
Senthil Kumar ThillaigovindhanDepartment of Computing Technologies, School of Computing, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent days, Internet of Medical Things (IoMT) and Deep Learning (DL) techniques are broadly used in medical data processing in decision-making. A lung tumour, one of the most dangerous medical diseases, requires early diagnosis with a higher precision rate. With that concern, this work aims to develop an Integrated Model (IM- LTS) for Lung Tumor Segmentation using Neural Networks (NN) and the Internet of Medical Things (IoMT). The model integrates two architectures, MobileNetV2 and U-NET, for classifying the input lung data. The input CT lung images are pre-processed using Z-score Normalization. The semantic features of lung images are extracted based on texture, intensity, and shape to provide information to the training network.•In this work, the transfer learning technique is incorporated, and the pre-trained NN was used as an encoder for the U-NET model for segmentation. Furthermore, Support Vector Machine is used here to classify input lung data as benign and malignant.•The results are measured based on the metrics such as, specificity, sensitivity, precision, accuracy and F-Score, using the data from benchmark datasets. Compared to the existing lung tumor segmentation and classification models, the proposed model provides better results and evidence for earlier disease diagnosis.

Indexed as

ClassificationIntegrated Model (IM- LTS) for Lung Tumor Segmentation]Internet of Medical Things (IoMT)Lung Tumor SegmentationNeural Networks (NN)Support Vector Machine

Identifiers

PMID40026592
PMCPMC11869539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.